Career history of Matthew During
Former positions of Matthew During
Companies | Position | Start | End |
---|---|---|---|
OVID THERAPEUTICS INC. | Director/Board Member | 2014-03-31 | 2019-03-31 |
Chief Executive Officer | 2014-03-31 | 2015-02-28 | |
Chief Tech/Sci/R&D Officer | 2015-02-28 | 2019-03-31 | |
Founder | 2014-03-31 | 2019-03-31 | |
President | 2015-02-28 | 2019-03-31 | |
Bridgewater Associates LP
Bridgewater Associates LP Investment ManagersFinance Bridgewater Associates LP (Bridgewater) is a registered investment advisor and fund of hedge funds manager headquartered in Westport, Connecticut. The firm was founded by Ray Dalio in 1975. They are a subsidiary of Bridgewater Associates Intermediate Holdings LP, which is owned by Bridgewater Associates Holdings, Inc. Bridgewater provides discretionary investment management services to pooled investment vehicles and single investor funds, and managed account clients. | Corporate Officer/Principal | 2014-01-31 | 2014-11-30 |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | 2005-12-31 | 2014-11-30 |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | Corporate Officer/Principal | - | 2005-12-31 |
Yale University | Corporate Officer/Principal | 1988-12-31 | 1999-12-31 |
NIGHTSTAR THERAPEUTICS PLC | Founder | 2013-12-31 | - |
Neurologix, Inc. /Old/ | Founder | - | - |
Merlin Pharma Pvt Ltd. | Founder | 1993-01-31 | - |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Founder | 2013-12-31 | - |
Training of Matthew During
Auckland University | Doctorate Degree |
Statistics
International
United States | 6 |
United Kingdom | 3 |
India | 2 |
Operational
Founder | 5 |
Corporate Officer/Principal | 4 |
Director/Board Member | 1 |
Sectoral
Consumer Services | 5 |
Health Technology | 3 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
OVID THERAPEUTICS INC. | Health Technology |
Private companies | 5 |
---|---|
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Health Services |
Bridgewater Associates LP
Bridgewater Associates LP Investment ManagersFinance Bridgewater Associates LP (Bridgewater) is a registered investment advisor and fund of hedge funds manager headquartered in Westport, Connecticut. The firm was founded by Ray Dalio in 1975. They are a subsidiary of Bridgewater Associates Intermediate Holdings LP, which is owned by Bridgewater Associates Holdings, Inc. Bridgewater provides discretionary investment management services to pooled investment vehicles and single investor funds, and managed account clients. | Finance |
Merlin Pharma Pvt Ltd. | |
Neurologix, Inc. /Old/ | Commercial Services |
Nightstar Therapeutics Ltd.
Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Matthew During
- Experience